Increased ErbB3 and EGFR activity mediate lapatinib resistance in prostate cancer

被引：0
|
作者：
Jathal, Maitreyee K. [1 ]
Steele, Thomas M. [2 ]
Mooso, Benjamin A. [2 ]
D'Abronzo, Leandro S. [1 ]
Siddiqui, Salma [2 ]
Drake, Christiana [1 ]
Ghosh, Paramita M. [1 ]
机构：
[1] Univ Calif Davis, Davis, CA USA
[2] VA Med Ctr, Sacramento, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3335
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer
    Koumakpayi, Ismael H.
    Diallo, Jean-Simon
    Le Page, Cecile
    Lessard, Laurent
    Filali-Mouhim, Abdelali
    Begin, Louis R.
    Mes-Masson, Anne-Marie
    Saad, Fred
    BJU INTERNATIONAL, 2007, 100 (02) : 303 - 309
  • [32] Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer
    Lin, Sue-Hwa
    Lee, Yu-Chen
    Choueiri, Michel B.
    Wen, Sijin
    Mathew, Paul
    Ye, Xiangcang
    Do, Kim-Anh
    Navone, Nora M.
    Kim, Jeri
    Tu, Shi-Ming
    Yu-Lee, Li-Yuan
    Logothetis, Christopher J.
    CLINICAL CANCER RESEARCH, 2008, 14 (12) : 3729 - 3736
  • [33] Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2
    Maurer, CA
    Friess, H
    Kretschmann, B
    Zimmermann, A
    Stauffer, A
    Baer, HU
    Korc, M
    Büchler, MW
    HUMAN PATHOLOGY, 1998, 29 (08) : 771 - 777
  • [34] Use of DARPP-32 to increase interactions between EGFR and ERBB3 and to promote gastric cancer resistance to gefitinib.
    Zhu, Shoumin
    Belkhiri, Abbes
    Zaika, Alexander
    El-Rifai, Wael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [35] Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells
    Liu, Bolin
    Ordonez-Ercan, Dalia
    Fan, Zeying
    Edgerton, Susan M.
    Yang, XiaoHe
    Thor, Ann D.
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (09) : 1874 - 1882
  • [36] Roles of cMET/ErbB3 activation and overexpression in the development or resistance to EGFR inhibitors in NSCLC patients.
    Ahn, Myung-Ju
    Park, Silvia
    Sun, Jong-Mu
    Ahn, Jin Seok
    Park, Keunchil
    Langley, Emma J.
    Kim, Phillip Sangwook
    Singh, Sharat
    Lockton, Steve
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] The ERBB3 receptor in cancer and cancer gene therapy
    G Sithanandam
    L M Anderson
    Cancer Gene Therapy, 2008, 15 : 413 - 448
  • [38] The ERBB3 receptor in cancer and cancer gene therapy
    Sithanandam, G.
    Anderson, L. M.
    CANCER GENE THERAPY, 2008, 15 (07) : 413 - 448
  • [39] HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3
    Chen, Jhen-Yu
    Chen, Yun-Ju
    Yen, Chia-Jui
    Chen, Wen-Shu
    Huang, Wei-Chien
    ONCOTARGET, 2016, 7 (01) : 473 - 489
  • [40] HBx SENSITIZE HEPATOCELLULAR CARCINOMA CELLS TO LAPATINIB BY UP-REGULATING ErbB3
    Chen, J. -Y.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S400 - S400
12345